778 results on '"Yoshii M"'
Search Results
252. Digital control for KEK-PS MA loaded RF system.
- Author
-
Yoshii, M., Ezura, E., Hashimoto, Y., Ohmori, C., Mori, Y., Takagi, A., Yamamoto, M., and Schnase, A.
- Published
- 2001
- Full Text
- View/download PDF
253. Synchrotron RF system for the JAERI-KEK Joint Project.
- Author
-
Ohmori, C., Ezura, E., Hashimoto, Y., Mori, Y., Takagi, A., Uesugi, T., Yoshii, M., Tamura, F., and Yamamoto, M.
- Published
- 2001
- Full Text
- View/download PDF
254. Recent beam studies of the PoP FFAG proton synchrotron.
- Author
-
Yoshimoto, M., Adachi, T., Aiba, M., Koba, K., Machida, S., Mori, Y., Muramatsu, R., Ohmori, C., Sakai, I., Sato, Y., Sugaya, M., Takagi, A., Ueno, R., Wada, M., Yokoi, T., Yoshii, M., and Yuasa, Y.
- Published
- 2001
- Full Text
- View/download PDF
255. A Case of Fundus Albipunctatus with a Retinol Dehydrogenase 5 Gene Mutation in a Child
- Author
-
Miyazaki, K., Murakami, A., Imamura, S., Yoshii, M., Ishida, M., Washio, N., and Okisaka, S.
- Published
- 2002
- Full Text
- View/download PDF
256. Longitudinal impedance tuner using high permeability material.
- Author
-
Koba, K., Arakawa, D., Fujieda, M., Ikegami, K., Ishi, Y., Kanai, Y., Kubota, C., Machida, S., Mori, Y., Ohmori, C., Shinto, K., Shibuya, S., Takagi, A., Toyama, T., Uesugi, T., Watanabe, T., Yamamoto, M., Yokoi, T., and Yoshii, M.
- Published
- 1999
- Full Text
- View/download PDF
257. Beam loading effects on high gradient MA-loaded cavity.
- Author
-
Yamamoto, M., Fujieda, M., Hashimoto, Y., Mori, Y., Muramatsu, R., Ohmori, C., Sato, Y., Takagi, A., Uesugi, T., and Yoshii, M.
- Published
- 1999
- Full Text
- View/download PDF
258. Multi-harmonic acceleration with high gradient MA cavity at HIMAC.
- Author
-
Yamamoto, M., Fujieda, M., Mori, Y., Muramatsu, R., Ohmori, C., Sato, Y., Takagi, A., Uesugi, T., Yoshii, M., Kanazawa, M., and Noda, K.
- Published
- 1999
- Full Text
- View/download PDF
259. Magnetic alloy loaded RF cavity for barrier bucket experiment at the AGS.
- Author
-
Fujieda, M., Iwashita, Y., Noda, A., Mori, Y., Ohmori, C., Sato, Y., Yoshii, M., Blaskiewicz, M., Brennan, J.M., Roser, T., Smith, K.S., Spitz, R., and Zaltsmann, A.
- Published
- 1999
- Full Text
- View/download PDF
260. The first beam acceleration test using high gradient cavity at HIMAC.
- Author
-
Muramatsu, R., Fujieda, M., Mori, Y., Nakayama, H., Ohmori, C., Sato, Y., Takagi, A., Uesugi, T., Yamamoto, M., Yoshii, M., Kanazawa, M., and Noda, K.
- Published
- 1999
- Full Text
- View/download PDF
261. High field-gradient cavities loaded with magnetic alloys for synchrotrons.
- Author
-
Ohmori, C., Ezura, E., Fujieda, M., Mori, Y., Muramatsu, R., Nakayama, H., Sato, Y., Takagi, A., Toda, M., Uesugi, T., Yamamoto, M., Yoshii, M., Kanazawa, M., and Noda, K.
- Published
- 1999
- Full Text
- View/download PDF
262. A wideband RF cavity for JHF synchrotrons.
- Author
-
Ohmori, C., Fujieda, M., Machida, S., Mori, Y., Nakayama, H., Saito, K., Sawada, S., Tanabe, Y., Yamamoto, M., Ezura, E., Takagi, A., Toda, M., Yoshii, M., Tanabe, T., and Uesugi, T.
- Published
- 1997
- Full Text
- View/download PDF
263. Studies of magnetic cores for JHF synchrotrons.
- Author
-
Fujieda, M., Mori, Y., Nakayama, H., Ohmori, C., Sawada, S., Tanabe, Y., Ezura, E., Takagi, A., Toda, M., and Yoshii, M.
- Published
- 1997
- Full Text
- View/download PDF
264. Intensity dependence of betatron resonances observed at the KEK-PS.
- Author
-
Shoji, Y., Arakawa, D., Kishiro, J., Koba, K., Machida, S., Marutsuka, K., Mori, Y., Ohmori, C., Sato, H., Shirakata, M., Takagi, H., Takayama, K., Toyama, T., and Yoshii, M.
- Published
- 1997
- Full Text
- View/download PDF
265. Microwave instability at transition crossing in the KEK-PS.
- Author
-
Takayama, K., Arakawa, D., Kishiro, J., Koba, K., Toyama, T., and Yoshii, M.
- Published
- 1997
- Full Text
- View/download PDF
266. A preliminary design of the PS collider.
- Author
-
Mori, Y., Yoshii, M., Toyama, T., Sakai, I., Shintomi, T., Suzuki, T., Ninomiya, S., Takagi, A., Sato, H., Hiramatsu, S., and Takasaki, E.
- Published
- 1991
- Full Text
- View/download PDF
267. Helium beam acceleration in the KEK proton synchrotron with a newly developed injection system for positive/negative ions.
- Author
-
Sakai, I., Takagi, A., Mori, Y., Machida, S., Yoshii, M., Toyama, T., Shirakata, M., Shoji, Y., and Sato, H.
- Published
- 1995
- Full Text
- View/download PDF
268. Direct fast beam chopping of H/sup -/ ion beam in the surface-plasma H/sup -/ ion source.
- Author
-
Shinto, K., Takagi, A., Igarashi, Z., Ikegami, K., Kinsho, M., Machida, S., Yoshii, M., and Mori, Y.
- Published
- 1995
- Full Text
- View/download PDF
269. Design study of antiproton accumulation and deceleration ring in the KEK PS complex.
- Author
-
Machida, S., Yoshii, M., Mori, Y., Tokuda, N., and Ishi, Y.
- Published
- 1995
- Full Text
- View/download PDF
270. Self-contained location detectors with fiber optic gyroscope and its application to the car location system.
- Author
-
Doi, Y., Maegawa, S., Yoshii, M., Hirano, K., and Matsuzaki, S.
- Published
- 1991
- Full Text
- View/download PDF
271. The decay of the [formula omitted] nuclide 59Zn
- Author
-
Arai, Y., Fujioka, M., Tanaka, E., Shinozuka, T., Miyatake, H., Yoshii, M., and Ishimatsu, T.
- Published
- 1981
- Full Text
- View/download PDF
272. ChemInform Abstract: Chemical State Analysis of Sn-Sb-O Solid Surfaces by Auger Electron Spectroscopy: Differentiation of Sb(III) and Sb(V).
- Author
-
KOMIYAMA, M., YOSHII, M., OGINO, Y., and ONO, T.
- Published
- 1992
- Full Text
- View/download PDF
273. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells
- Author
-
Yoshii, M. and Watabe, S.
- Published
- 1994
- Full Text
- View/download PDF
274. Differential inhibition of transient and long-lasting calcium channel currents by benzodiazepines in neuroblastoma cells
- Author
-
Watabe, S., Yoshii, M., Ogata, N., and Tsunoo, A.
- Published
- 1993
- Full Text
- View/download PDF
275. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension.
- Author
-
Takiuchi, S., Kamide, K., Miwa, Y., Tomiyama, M., Yoshii, M., Matayoshi, T., Horio, T., and Kawano, Y.
- Subjects
- *
CAROTID artery , *TARGET organs (Anatomy) , *PATIENTS , *HYPERTENSION , *TARGETED drug delivery , *ARTERIOSCLEROSIS , *ALBUMINURIA - Abstract
Carotid intima-media thickness (IMT) assessed by ultrasonography is regarded as an early predictor of general arteriosclerosis in patients with essential hypertension. However, the methods of measuring IMT have not been globally standardized, and it remains unclear whether conventional measurement of IMT represents the prevalence of hypertensive target organ damage. In this study, we verified the association between several commonly used carotid ultrasonographical parameters and the severity of hypertensive target organ damage (retinal arteriosclerosis, microalbuminuria, left ventricular hypertrophy (LVH)). Carotid ultrasonography, echocardiography, urinalysis, and funduscopy were performed in 184 patients (64 ± 12 years, 96 males and 88 females) with various stages of essential hypertension. Carotid arteriosclerosis was assessed using four methodologically different methods: conventional-IMT, maximum-IMT (Max-IMT), Mean-IMT, and Plaque Score (the sum of all plaque thicknesses). Age and all carotid ultrasonographical parameters were significantly associated with albuminuria, retinal arteriosclerosis, and left ventricular mass index. High-sensitivity CRP was significantly correlated with retinopathy and LVH. Carotid parameters in patients with histories of cardiovascular events were significantly greater in those without events. Among all carotid parameters, Max-IMT showed the highest correlation coefficient of the severity of target organ damage, and showed significant association with CRP. Stepwise regression analysis revealed that Max-IMT was the independent factor for predicting target organ damage. Max-IMT is suggested to be the most reliable and simplest parameter for predicting hypertensive target organ damage including microangiopathy in patients with essential hypertension.Journal of Human Hypertension (2004) 18, 17-23. doi:10.1038/sj.jhh.1001628 [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
276. Head-tail instability and microwave instability in the KEK-PS
- Author
-
Yoshii, M [KEK, High Energy Accelerator Research Organization 1-1 Oho, Tsukuba-shi, Ibaraki-ken 305-0801 (Japan)]
- Published
- 1999
- Full Text
- View/download PDF
277. Impedance budget and beam instabilities of the JHF 50-GeV proton synchrotron
- Author
-
Yoshii, M [KEK, Oho I-1, Tsukuba-shi, Ibaraki-ken (Japan)]
- Published
- 1999
- Full Text
- View/download PDF
278. Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension.
- Author
-
Tsukada, K, Ishimitsu, T, Teranishi, M, Saitoh, M, Yoshii, M, Inada, H, Ohta, S, Akashi, M, Minami, J, Ono, H, Ohrui, M, and Matsuoka, H
- Subjects
- *
HYPERTENSION , *GENETIC polymorphisms , *ALDOSTERONE - Abstract
Predispositions to essential hypertension and cardiovascular diseases are possibly associated with gene polymorphisms of the renin-angiotensin system. Gene polymorphisms of angiotensinogen and angiotensin- converting enzyme genes have been suggested to be risk factors for hypertension and myocardial infarction. Concerning the polymorphism of aldosterone synthase (CYP11B2) gene, earlier studies have shown inconsistent results in terms of its relation to hypertension. In the present case-control study, we investigated the association of -344T/C polymorphism in the promoter region of human CYP11B2 gene with genetic predisposition to hypertension. The genotype of -344T/C polymorphism was determined in essential hypertension subjects (n=250) and normotensive subjects (n=221). The distributions of three genotypes (TT, TC, and CC) were significantly different between the hypertensive and the normotensive groups (???[SUP2] = 9.61, P = 0.008). Namely, the frequency of C allele was higher in the hypertensive patients than in the normotensive subjects (34.2 vs 26.5%, P=0.010). Our data suggest that the -344C allele of CYP11B2 gene polymorphism is associated with the genetic predisposition to develop essential hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
279. The significance of the free‐to‐complexed prostate‐specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1–10.0 ng/mL.
- Author
-
Okegawa, T., Kinjo, M., Watanabe, K., Noda, H., Kato, M., Miyata, A., Murata, A., Yoshii, M., Nutahara, K., and Higashihara, E.
- Subjects
- *
PROSTATE-specific antigen , *PROSTATE cancer , *DIAGNOSIS - Abstract
Objective To compare the ratio of free prostate specific antigen (fPSA), total PSA (tPSA) and complexed PSA (cPSA, measured using a novel immunoassay) with other variables used to detect prostate cancer in patients with intermediate serum PSA levels of 4.1–10.0 ng/mL. Patients and methods From July 1997 to August 1998, 140 consecutive patients were assessed; all had intermediate serum PSA levels and/or abnormal findings on a digital rectal examination. All patients underwent transrectal ultrasonography (TRUS)‐guided biopsy, and the prostate and transition zone volumes were determined by TRUS. Free and tPSA were measured using the Tandem‐R assay (Hybritech Corp., San Diego, CA). PSA complexed with α1‐antichymotrypsin (cPSA) was measured using an appropriate assay. The ability of cPSA, free‐to‐total PSA ratio (f/tPSA), free‐to‐complexed PSA ratio (f/cPSA), tPSA density of the whole prostate (PSAD), of the transition zone (tPSATZ), and cPSA density of the whole prostate (cPSAD) and of the transition zone (cPSATZ) to improve the power of PSA in detecting prostate cancer was evaluated using receiver operating characteristic (ROC) curves. Results Of the 140 patients, 126 had histologically confirmed benign disease and 14 had prostate cancer. The cPSA alone had better specificity for detecting prostate cancer than had tPSA alone but the difference was not significant. The area under the ROC curve for f/cPSA was larger than those for all other variables. With a 93% sensitivity for detecting prostate cancer, a f/cPSA threshold of 25% would result in fewer unnecessary biopsies (40% f/cPSA specificity) than with all other PSA variables. The difference in the resolution was significant between f/cPSA and tPSA, cPSA, tPSAD and tPSATZ, but not with f/tPSA, cPSAD or cPSATZ. In patients with a prostate volume of < 30 mL, the cPSATZ showed better specificity for prostate cancer than tPSA alone. Conclusion Measuring the level of cPSA and its derivatives may provide better differentiation of prostate cancer and benign disease than tPSA alone in patients with a tPSA level of 4.1–10.0 ng/mL. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
280. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
- Author
-
Bonaventure, A., Harewood, R., Stiller, C.A., Gatta, G., Clavel, J., Stefan, D.C., Carreira, H., Spika, D., Marcos-Gragera, R., Peris-Bonet, R., Piñeros, M., Sant, M., Kuehni, C.E., Murphy, MFG, Coleman, M.P., Allemani, C., CONCORD Working Group, Bouzbid, S., Hamdi-Chérif, M., Zaidi, Z., Bah, E., Swaminathan, R., Nortje, S.H., El Mistiri, M.M., Bayo, S., Malle, B., Manraj, S.S., Sewpaul-Sungkur, R., Ogunbiyi, O.J., Bradshaw, D., Somdyala, N., Stefan, D.C., Abdel-Rahman, M., Jaidane, L., Mokni, M., Kumcher, I., Moreno, F., González, M.S., Laura, E.A., Espinola, S.B., Calabrano, G.H., Carballo Quintero, B., Fita, R., Garcilazo, D.A., Giacciani, P.L., Diumenjo, M.C., Laspada, W.D., Green, M.A., Lanza, M.F., Ibañez, S.G., Lima, C.A., de Oliveira, E.L., Daniel, C., Scandiuzzi, C., De Souza, P., Melo, C.D., Del Pino, K., Laporte, C., Curado, M.P., de Oliveira, J.C., Veneziano, C., Veneziano, D.B., Azevedo E Silva, G., Galaz, J.C., Moya, J.A., Herrmann, D.A., Vargas, S., Herrera, V.M., Uribe, C.J., Bravo, L.E., Arias-Ortiz, N.E., Jurado, D.M., Yépez, M.C., Galán, Y.H., Torres, P., Martínez-Reyes, F., Pérez-Meza, M.L., Jaramillo, L., Quinto, R., Cueva, P., Yépez, J.G., Torres-Cintrón, C.R., Tortolero-Luna, G., Alonso, R., Barrios, E., Nikiforuk, C., Shack, L., Coldman, A.J., Woods, R.R., Noonan, G., Turner, D., Kumar, E., Zhang, B., McCrate, F.R., Ryan, S., Hannah, H., Dewar, R., MacIntyre, M., Lalany, A., Ruta, M., Marrett, L., Nishri, D.E., McClure, C., Vriends, K.A., Bertrand, C., Louchini, R., Robb, K.I., Stuart-Panko, H., Demers, S., Wright, S., George, J.T., Shen, X., Brockhouse, J.T., O'Brien, D.K., Ward, K.C., Almon, L., Bates, J., Rycroft, R., Mueller, L., Phillips, C., Brown, H., Cromartie, B., Schwartz, A.G., Vigneau, F., MacKinnon, J.A., Wohler, B., Bayakly, A.R., Clarke, C.A., Glaser, S.L., West, D., Green, M.D., Hernandez, B.Y., Johnson, C.J., Jozwik, D., Charlton, M.E., Lynch, C.F., Huang, B., Tucker, T.C., Deapen, D., Liu, L., Hsieh, M.C., Wu, X.C., Stern, K., Gershman, S.T., Knowlton, R.C., Alverson, J., Copeland, G.E., Rogers, D.B., Lemons, D., Williamson, L.L., Hood, M., Hosain, G.M., Rees, J.R., Pawlish, K.S., Stroup, A., Key, C., Wiggins, C., Kahn, A.R., Schymura, M.J., Leung, G., Rao, C., Giljahn, L., Warther, B., Pate, A., Patil, M., Schubert, S.S., Rubertone, J.J., Slack, S.J., Fulton, J.P., Rousseau, D.L., Janes, T.A., Schwartz, S.M., Bolick, S.W., Hurley, D.M., Richards, J., Whiteside, M.A., Nogueira, L.M., Herget, K., Sweeney, C., Martin, J., Wang, S., Harrelson, D.G., Cheteri, M.K., Farley, S., Hudson, A.G., Borchers, R., Stephenson, L., Espinoza, J.R., Weir, H.K., Edwards, B.K., Wang, N., Yang, L., Chen, J.S., Song, G.H., Gu, X.P., Zhang, P., Ge, H.M., Zhao, D.L., Zhang, J.H., Zhu, F.D., Tang, J.G., Shen, Y., Wang, J., Li, Q.L., Yang, X.P., Dong, J., Li, W., Cheng, L.P., Chen, J.G., Huang, Q.H., Huang, S.Q., Guo, G.P., Wei, K., Chen, W.Q., Zeng, H., Demetriou, A.V., Pavlou, P., Mang, W.K., Ngan, K.C., Kataki, A.C., Krishnatreya, M., Jayalekshmi, P.A., Sebastian, P., Sapkota, S.D., Verma, Y., Nandakumar, A., Suzanna, E., Keinan-Boker, L., Silverman, B.G., Ito, H., Nakagawa, H., Hattori, M., Kaizaki, Y., Sugiyama, H., Utada, M., Katayama, K., Narimatsu, H., Kanemura, S., Koike, T., Miyashiro, I., Yoshii, M., Oki, I., Shibata, A., Matsuda, T., Nimri, O., Ab Manan, A., Pathy, N.B., Chimedsuren, O., Tuvshingerel, S., Al Khater, A., Al-Eid, H., Jung, K.W., Won, Y.J., Chiang, C.J., Lai, M.S., Suwanrungruang, K., Wiangnon, S., Daoprasert, K., Pongnikorn, D., Geater, S.L., Sriplung, H., Eser, S., Yakut, C.I., Hackl, M., Mühlböck, H., Oberaigner, W., Zborovskaya, A.A., Aleinikova, O.V., Henau, K., Van Eycken, L., Dimitrova, N., Valerianova, Z., Šekerija, M., Zvolský, M., Engholm, G., Storm, H., Innos, K., Mägi, M., Malila, N., Seppä, K., Jégu, J., Velten, M., Cornet, E., Troussard, X., Bouvier, A.M., Faivre, J., Guizard, A.V., Bouvier, V., Launoy, G., Arveux, P., Maynadié, M., Mounier, M., Fournier, E., Woronoff, A.S., Daoulas, M., Clavel, J., Le Guyader-Peyrou, S., Monnereau, A., Trétarre, B., Colonna, M., Cowppli-Bony, A., Molinié, F., Bara, S., Degré, D., Ganry, O., Lapôtre-Ledoux, B., Grosclaude, P., Estève, J., Bray, F., Piñeros, M., Sassi, F., Stabenow, R., Eberle, A., Erb, C., Nennecke, A., Kieschke, J., Sirri, E., Kajueter, H., Emrich, K., Zeissig, S.R., Holleczek, B., Eisemann, N., Katalinic, A., Brenner, H., Asquez, R.A., Kumar, V., Ólafsdóttir, E.J., Tryggvadóttir, L., Comber, H., Walsh, P.M., Sundseth, H., Devigili, E., Mazzoleni, G., Giacomin, A., Bella, F., Castaing, M., Sutera, A., Gola, G., Ferretti, S., Serraino, D., Zucchetto, A., Lillini, R., Vercelli, M., Busco, S., Pannozzo, F., Vitarelli, S., Ricci, P., Pascucci, C., Autelitano, M., Cirilli, C., Federico, M., Fusco, M., Vitale, M.F., Usala, M., Cusimano, R., Mazzucco, W., Michiara, M., Sgargi, P., Maule, M.M., Sacerdote, C., Tumino, R., Di Felice, E., Vicentini, M., Falcini, F., Cremone, L., Budroni, M., Cesaraccio, R., Contrino, M.L., Tisano, F., Fanetti, A.C., Maspero, S., Candela, G., Scuderi, T., Gentilini, M.A., Piffer, S., Rosso, S., Sacchetto, L., Caldarella, A., La Rosa, F., Stracci, F., Contiero, P., Tagliabue, G., Dei Tos, A.P., Zorzi, M., Zanetti, R., Baili, P., Berrino, F., Gatta, G., Sant, M., Capocaccia, R., De Angelis, R., Liepina, E., Maurina, A., Smailyte, G., Agius, D., Calleja, N., Siesling, S., Visser, O., Larønningen, S., Møller, B., Dyzmann-Sroka, A., Trojanowski, M., Gózdz, S., Mezyk, R., Gradalska-Lampart, M., Radziszewska, A.U., Didkowska, J.A., Wojciechowska, U., Blaszczyk, J., Kepska, K., Bielska-Lasota, M., Kwiatkowska, K., Forjaz, G., Rego, R.A., Bastos, J., Silva, M.A., Antunes, L., Bento, M.J., Mayer-da-Silva, A., Miranda, A., Coza, D., Todescu, A.I., Valkov, M.Y., Adamcik, J., Safaei Diba, C., Primic-Žakelj, M., Žagar, T., Stare, J., Almar, E., Mateos, A., Quirós, J.R., Bidaurrazaga, J., Larrañaga, N., Díaz García, J.M., Marcos, A.I., Marcos-Gragera, R., Vilardell Gil, M.L., Molina, E., Sánchez, M.J., Sureda, P.F., Montserrat, M.R., Chirlaque, M.D., Navarro, C., Ardanaz, E.E., Moreno-Iribas, C.C., Fernández-Delgado, R., Peris-Bonet, R., Galceran, J., Khan, S., Lambe, M., Camey, B., Bouchardy, C., Usel, M., Ess, S.M., Herrmann, C., Bulliard, J.L., Maspoli-Conconi, M., Frick, H., Kuehni, C.E., Schindler, M., Bordoni, A., Spitale, A., Chiolero, A., Konzelmann, I., Dehler, S.I., Matthes, K.L., Rashbass, J., Stiller, C.A., Fitzpatrick, D., Gavin, A., Bannon, F., Black, R.J., Brewster, D.H., Huws, D.W., White, C., Finan, P., Allemani, C., Bonaventure, A., Carreira, H., Coleman, M.P., Di Carlo, V., Harewood, R., Liu, K., Matz, M., Montel, L., Nikšić, M., Rachet, B., Sanz, N., Spika, D., Stephens, R., Peake, M., Murphy, M., Chalker, E., Newman, L., Baker, D., Soeberg, M.J., Aitken, J., Scott, C., Stokes, B.C., Venn, A., Farrugia, H., Giles, G.G., Threlfall, T., Currow, D., You, H., Hendrix, J., Lewis, C., Latorre, M.R., and Tanaka, L.F.
- Subjects
360 Social problems & social services ,610 Medicine & health - Abstract
BACKGROUND Global inequalities in access to health care are reflected in differences in cancer survival. The CONCORD programme was designed to assess worldwide differences and trends in population-based cancer survival. In this population-based study, we aimed to estimate survival inequalities globally for several subtypes of childhood leukaemia. METHODS Cancer registries participating in CONCORD were asked to submit tumour registrations for all children aged 0-14 years who were diagnosed with leukaemia between Jan 1, 1995, and Dec 31, 2009, and followed up until Dec 31, 2009. Haematological malignancies were defined by morphology codes in the International Classification of Diseases for Oncology, third revision. We excluded data from registries from which the data were judged to be less reliable, or included only lymphomas, and data from countries in which data for fewer than ten children were available for analysis. We also excluded records because of a missing date of birth, diagnosis, or last known vital status. We estimated 5-year net survival (ie, the probability of surviving at least 5 years after diagnosis, after controlling for deaths from other causes [background mortality]) for children by calendar period of diagnosis (1995-99, 2000-04, and 2005-09), sex, and age at diagnosis (
- Published
- 2017
281. Enterovirus encephalomyelitis in pigs in Japan caused by porcine teschovirus.
- Author
-
Yamada, M., Nakamura, K., Kaku, Y., Yoshii, M., Haritani, M., Kozakura, R., and Ikegami, R.
- Subjects
- *
ENCEPHALOMYELITIS , *SWINE , *AUTOPSY , *DORSAL root ganglia , *CENTRAL nervous system , *SPINAL nerve roots - Abstract
This article discusses enterovirus encephalomyelitis in pigs in Japan, caused by porcine teschovirus (ptv). Enterovirus encephalomyelitis is a non-suppurative encephalomyelitis of pigs that can be fatal. The disease has been identified in different forms, such as Teschen disease, Talfan disease, and poliomyelitis suum. This article describes the histological features of porcine enterovirus encephalomyelitis in piglets in Japan, caused by ptv. The study found that the lesions were limited to the central nervous system and peripheral nerve fibers, and ptv was isolated from the cerebellum and brainstem. This is the first report of enterovirus encephalomyelitis in pigs in Japan. [Extracted from the article]
- Published
- 2004
- Full Text
- View/download PDF
282. Radio frequency beam chopping in a surface-plasma-type negative-ion source.
- Author
-
Shinto, K., Takagi, A., Kinsho, M., Ikegami, K., Igarashi, Z., Machida, S., Yoshii, M., and Mori, Y.
- Subjects
- *
ION bombardment , *RADIO frequency modulation , *HYDROGEN ions , *ANIONS , *SYNCHROTRON radiation sources - Abstract
Proposes a method for radio frequency (rf) beam chopping in a surface-plasma-type negative-ion source. Circuit diagram of the rf modulated power supply; Acceleration of the direct fast-chopped H[sup -] beam; Longitudinal emittance of the direct fast-chopped H[sup -] beam in the booster synchrotron.
- Published
- 1996
- Full Text
- View/download PDF
283. EP-1135: Should level IIb nodes be irradiated in definitive radiotherapy for supraglottic cancer?
- Author
-
Kanayama, N., Kawaguchi, Y., Konishi, K., Teshima, T., Nishiyama, K., Yoshii, M., Suzuki, M., Fujii, T., and Yoshino, K.
- Subjects
- *
CANCER radiotherapy , *ONCOLOGY research , *RADIATION doses , *MEDICAL research , *MEDICAL care - Published
- 2014
- Full Text
- View/download PDF
284. Neuronal activities in the parietal cortex of an EL and DDY mouse
- Author
-
Suzuki, Jiro, Ozawa, N., Murashima, Y.L., Shinba, T., and Yoshii, M.
- Published
- 2007
- Full Text
- View/download PDF
285. A unique compound ameliorating endoplasmic reticulum stress and insulin resistance by binding to β tubulin.
- Author
-
Horiuchi K, Matsushima G, Wada M, Thon M, Sobhy MH, Ayoub AT, Hara M, Yoshii M, Arakawa K, Ozawa K, and Hosoi T
- Subjects
- Animals, Mice, Male, Humans, Mice, Inbred C57BL, Protein Binding, Insulin metabolism, Hypoglycemic Agents pharmacology, Endoplasmic Reticulum Stress drug effects, Tubulin metabolism, Insulin Resistance, Apigenin pharmacology
- Abstract
Insulin is secreted by the pancreatic β-cells and regulates glucose uptake. Endoplasmic reticulum (ER) stress is known to induce insulin resistance. Identifying novel compounds, which can ameliorate ER stress and insulin resistance may be beneficial in the treatment of diabetes. Since treatment with compounds sourced from edible plants is relatively safe, this study aimed to identify a plant-derived potential compound attenuating insulin resistance. In the present study, we identified apigenin as an effective compound for ameliorating ER stress and insulin resistance. It attenuated ER stress-induced cell death and hepatic insulin resistance and improved abnormal glucose tolerance in a db/db diabetic model. The molecular mechanism of apigenin involved direct binding to β-tubulin and improving tubulin stability, thereby recovering insulin resistance and developing diabetes. To our knowledge, no known antidiabetic drugs are yet known to target β-tubulin. Edible plants containing apigenins, such as onions, oranges, and parsley, have been consumed since a long time. Therefore, the use of natural edible plants as a source may offer a safe strategy for the prevention of diabetes., (© 2024 The Author(s). The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)
- Published
- 2024
- Full Text
- View/download PDF
286. Significance of the geriatric nutritional risk index and neutrophil-to-lymphocyte ratio as prognostic indicators in older patients with gastric cancer: a retrospective cohort study.
- Author
-
Miyamoto H, Toyokawa T, Ishidate T, Kuroda K, Miki Y, Yoshii M, Tamura T, Lee S, and Maeda K
- Subjects
- Humans, Male, Aged, Female, Retrospective Studies, Prognosis, Aged, 80 and over, Nutritional Status, ROC Curve, Gastrectomy, Lymphocyte Count, Stomach Neoplasms mortality, Stomach Neoplasms blood, Stomach Neoplasms surgery, Stomach Neoplasms pathology, Neutrophils, Nutrition Assessment, Lymphocytes, Geriatric Assessment methods
- Abstract
Background: The number of older patients with cancer is increasing with the progression of aging societies. In the current study, we sought to clarify the prognostic values of the geriatric nutritional risk index (GNRI) as a nutritional index and the neutrophil-to-lymphocyte ratio (NLR) as an inflammatory index in older patients with gastric cancer., Methods: Between January 2007 and December 2016, a total of 197 consecutive gastric cancer patients aged ≥ 75 years who underwent radical gastrectomy were enrolled in this study. The prognostic values of preoperative GNRI and NLR were assessed using time-dependent receiver operating characteristic curve analysis, log-rank tests, and Cox regression analysis., Results: The areas under the curve (AUCs) predicting 5-year overall survival (OS) were 0.668 for GNRI and 0.637 for NLR. The 5-year OS rates in the groups with low GNRI and NLR were 40.1% and 74.1% (p < 0.001), and those with high GNRI and NLR were 70.7% and 41.5% (p < 0.001), respectively. Multivariate analysis showed that GNRI (hazard ratio (HR): 0.584; 95% confidence interval (CI): 0.356-0.960; p = 0.034) and NLR (HR: 2.470; 95% CI: 1.503-4.059; p < 0.001) were independent predictors for OS. The GNRI-NLR score constructed with GNRI and NLR had a higher AUC (0.698) than those of GNRI or NLR alone and was an independent prognostic factor (HR, 0.486; 95% CI: 0.363-0.651; p < 0.001)., Conclusions: GNRI and NLR are useful prognostic biomarkers in older patients with gastric cancer aged ≥ 75 years. The GNRI-NLR score could contribute to a more personalized and holistic approach to cancer treatment in this patient population., Competing Interests: Declarations Ethics approval and consent to participate This retrospective study was approved by the Ethics Committee of Osaka Metropolitan University Graduate School of Medicine (approval no. 2023-013) and conducted in accordance with the principles of the Declaration of Helsinki. Due to the retrospective nature of the study, we used the opt-out approach to disclose the study information instead of written informed consent. We obtained an " informed consent waiver" from the Ethical Committee of Osaka Metropolitan University Graduate School of Medicine. Consent for publication Not applicable. Competing interests The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
287. Robot-assisted minimally invasive esophagectomy for esophageal cancer in the left lateral decubitus position.
- Author
-
Lee S, Tamura T, Miki Y, Nishi S, Miyamoto H, Ishidate T, Kasashima H, Fukuoka T, Yoshii M, Shibutani M, Toyokawa T, and Maeda K
- Abstract
Background: The use of robot-assisted minimally invasive esophagectomy (RAMIE) in the prone position for esophageal cancer has been currently increasing worldwide. In future, as surgical-assisted robots become more widespread, it is estimated that only two methods of transthoracic approach will remain: RAMIE and open thoracotomy for thoracic esophageal cancer. RAMIE in the left lateral decubitus position (RAMIE-LLDP) has the same field of view as open thoracotomy, is safe in emergency situations, and provides education on open thoracotomy., Methods: Between September 2020 and April 2024, RAMIE-LLDP was performed in 64 consecutive patients with esophageal cancer. RAMIE-LLDP was performed with the operating table rotated and tilted 45° to the ventral side under artificial pneumothorax. The hand-control setting of the surgical-assist robot system was reversed left to right when the Patient Cart was rolled from the same direction as the RAMIE in the prone position., Results: The mean total surgery and console times during the thoracic procedure were 254-min overall and 225 min in the last 24 cases and 195-min overall and 178- min in the last 24 cases, respectively. The mean amount of blood loss was 203.4 g overall and 28.3 g in the last 24 cases. Postoperative recurrent laryngeal nerve palsy with Clavien-Dindo classification (CD) was ≥ 2 in six patients (9.4%). Postoperative pneumonia with CD ≥ 2 was observed in 11 patients (17.2%). Conversion to open thoracotomy was observed in three patients (4.7%). In all three patients, an immediate conversion to thoracotomy without patients' position change was actually possible and no serious complications were noted. No mortality occurred within 30 days postoperatively., Conclusion: RAMIE-LLDP which facilitates emergency thoracotomy has perioperative results comparable to those of conventional thoracoscopic esophagectomy and is educational for open surgery. RAMIE-LLDP is the safest and most optimal surgery for esophageal cancer., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
288. Synergetic inhibitory effect of isopropyl methylphenol-based agents on biofilm formation by Streptococcus mutans.
- Author
-
Korenaga A, Miyaoka T, Asami H, Yamagami Y, Yoshii M, Tanaka S, and Nagao T
- Subjects
- Drug Synergism, Microbial Sensitivity Tests, Gene Expression Regulation, Bacterial drug effects, Phenols pharmacology, Anti-Bacterial Agents pharmacology, Castor Oil, Humans, Polyethylene Glycols pharmacology, Biofilms drug effects, Biofilms growth & development, Streptococcus mutans drug effects
- Abstract
Dental caries and periodontitis are the most common oral diseases in humans and the main causes of tooth loss. Streptococcus mutans is primarily responsible for dental caries and dental plaque, which are triggered by biofilm formation on the tooth surface. In this study, biofilm inhibition by 4-isopropyl-3-methylphenol (IPMP)-based agents, consisting of IPMP and polyoxyethylene-hydrogenated castor oil (POEHCO), was investigated in vitro. Notably, the use of POEHCO in addition to IPMP inhibited S. mutans biofilms more drastically than IPMP alone. Moreover, the effects of IPMP on the expression of biofilm-related genes (gtfB, gtfC, and gtfD) were examined using quantitative real-time PCR. IPMP at sub-minimum inhibitory concentrations significantly downregulated the expression of these genes. These results suggested that the inhibitory effects on biofilm formation were synergistically enhanced by the surfactant and antibiofilm activities of IPMP. Therefore, IPMP-based agents as dentifrices may be useful to prevent oral diseases originating from biofilms., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Korenaga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
289. Successful resection of a rectal gastrointestinal stromal tumor using a transperineal approach: a case report.
- Author
-
Endo Y, Fukuoka T, Ozawa S, Ishidate T, Yonemitsu K, Seki Y, Kasashima H, Miki Y, Yoshii M, Tamura T, Shibutani M, Toyokawa T, Lee S, and Maeda K
- Abstract
Background: Rectal gastrointestinal stromal tumors (GISTs) complicate surgical approaches because of their anatomical position. We herein report a patient with rectal GIST on the anterior wall of the lower rectum, hat was successfully resected using a transperineal approach., Case Presentation: This report describes a unique case of a 73-year-old man who was diagnosed with rectal GIST on the anterior wall of the lower rectum. The tumor was located within 3 cm of the anal verge, a location that would require highly invasive surgery. A transperineal approach was planned to preserve the anal function. Under general anesthesia, the patient was placed in a lithotomy position and a Mercedes-Benz incision was made in the perineum. Excision of the tumor was performed. The post-operative course was uneventful, and the patient remained free from recurrence., Conclusion: This case highlights the importance of performing minimally invasive and safe surgery. With some surgical refinements, a transperineal approach may be an option for surgical procedures in patients with rectal GIST on the anterior wall of the lower rectum., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
290. Prognostic Impact of Tumor Growth Rate During Second-line Chemotherapy in Patients With Gastric Cancer.
- Author
-
Yoshii M, Miki Y, Tanaka H, Tamura T, Toyokawa T, Lee S, and Maeda K
- Abstract
Background/aim: Despite the remarkable developments in chemotherapy for gastric cancer (GC), rapid tumor growth is sometimes experienced during chemotherapy. This study investigated the association of tumor growth rate (TGR) during second-line chemotherapy with the prognosis of patients with GC., Patients and Methods: We retrospectively reviewed 29 patients with GC treated with nab-paclitaxel plus ramucirumab as second-line chemotherapy between 2017 and 2019 at Osaka Metropolitan University. Of them, 13 cases with target lesions were classified into two groups according to TGR using a cutoff value of 0.25. Clinicopathological factors and survival outcomes were compared between the high TGR (n=5) and low TGR (n=8) groups., Results: The median duration of first-line chemotherapy was significantly longer in the high TGR group than in the low TGR group [median 298 days vs. 72.5 days, p=0.030]. Progressive disease (PD) was observed in 60% of patients with high TGR, whereas stable disease (SD) was observed in 75% patients with low TGR. The median survival time (MST) after starting chemotherapy was 488 days in the low TGR group but was not reached in the high TGR group (log rank p=0.215). The MST after PD was 145 days in the low TGR group but was not estimated in the high TGR group (log rank p=0.345)., Conclusion: Based on the absence of significant differences in survival outcomes between the high and low TGR groups, sequential late-line chemotherapy might be considered important, even for patients with high TGR., Competing Interests: There are no financial or other interests that might be construed as a conflict of interest with regard to the submitted manuscript., (©2024 The Author(s). Published by the International Institute of Anticancer Research.)
- Published
- 2024
- Full Text
- View/download PDF
291. Utility of Assessing Early Tumor Shrinkage as an Efficacy Predictor in Patients with Non-Surgically Indicated or Recurrent Esophageal Cancer Treated with Nivolumab plus Ipilimumab.
- Author
-
Natsuki S, Lee S, Kasashima H, Miki Y, Fukuoka T, Yoshii M, Tamura T, Shibutani M, Toyokawa T, Tanaka H, and Kiyoshi M
- Abstract
Introduction: Nivolumab plus ipilimumab combination therapy has been administered as a first-line treatment in Japan since 2022 for patients with unresectable progressive or recurrent esophageal cancer. The efficacy and safety of this immune checkpoint inhibitor (ICI) doublet therapy are now being evaluated, and it is necessary to identify populations that benefit from this treatment at an early phase after initiation. For patients not showing early benefit, changing as soon as possible to other therapeutic strategies could improve their survival outcomes. Therefore, we attempted to identify decision-making factors such as early tumor shrinkage (ETS) based on treatment experience with ICI doublet therapy., Methods: The study included 19 patients who received nivolumab plus ipilimumab for non-surgically indicated or recurrent esophageal cancer between July 2022 and November 2023. Tumors were assessed approximately every 2 months after treatment initiation. The effects of ETS, depth of response (DpR), and clinicopathologic features, including immune-related adverse events (irAEs), on progression-free and overall survival were evaluated using Kaplan-Meier plots and Cox proportional hazard models., Results: The mean duration of ICI doublet administration was 5.89 months (range, 1-16 months). At first evaluation, patients who exhibited no tumor progression >20% indicated possible response to ICI doublet therapy, and patients whose tumors shrank even minimally exhibited favorable progression-free survival. Higher DpR at any cut-off line exhibited better progression-free survival than those with lower DpR. Fifteen patients experienced irAEs, with 13 of these patients experiencing irAEs within 3 months of treatment initiation. irAEs were associated with the efficacy of ICI doublet therapy, but efficacy could not be predicted based on early irAE experience., Conclusion: ETS-high, DpR-high, and irAEs might be associated with favorable responses to nivolumab plus ipilimumab. As a predictor of efficacy at an early phase, ETS >0% could be a deciding factor for continuing ICI doublet therapy., (© 2024 S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
292. The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
- Author
-
Tsujio G, Fukuoka T, Sugimoto A, Yonemitsu K, Seki Y, Kasashima H, Miki Y, Yoshii M, Tamura T, Shibutani M, Toyokawa T, Lee S, and Maeda K
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Retrospective Studies, Preoperative Care, Cathartics therapeutic use, Aged, 80 and over, Metronidazole therapeutic use, Metronidazole administration & dosage, Risk Factors, Surgical Wound Infection prevention & control, Surgical Wound Infection etiology, Propensity Score, Colorectal Neoplasms surgery
- Abstract
Background/aim: In colorectal cancer surgery, the risk of surgical site infection (SSI) is relatively high. The development of SSI is related to longer and costlier hospitalization and reduced quality of life; therefore, perioperative prevention of SSI is important. Chemical bowel preparation (CBP) combined with mechanical bowel preparation (MBP) may be more effective in preventing surgical site infection (SSI) compared to MBP alone. Since May 2021, we have been administering oral kanamycin and metronidazole as CBP, in addition to MBP, as a preoperative treatment for colorectal cancer surgery on the day before surgery. In this study, we investigated the clinical value of CBP in addition to MBP in colorectal cancer surgery using propensity score matching (PSM)., Patients and Methods: From January 2017 to December 2021, 136 consecutive patients underwent radical surgery for sigmoid colon and rectal cancer at the Osaka Metropolitan University Hospital. Patients were divided into two groups: CBP and N-CBP. In the N-CBP group, we performed only preoperative MBP, whereas in the CBP group, we performed preoperative CBP in addition to MBP. We retrospectively analyzed this relationship with PSM., Results: Overall, 46 patients underwent preoperative CBP and MBP, 90 patients underwent preoperative MBP only. PSM was performed between the CBP and N-CBP groups based on the following ten factors: age, sex, diabetes mellitus, preoperative therapy, Glasgow Prognostic Score (GPS), operative time, blood loss, stoma, and pathological stage. After PSM, univariate and multivariate analyses of the relationship between SSI and clinicopathological factors were performed. Univariate analysis showed that age and CBP were correlated with the rate of SSI (p=0.039 and p=0.017, respectively), whereas sex was relatively correlated with the rate of SSI (p=0.066). The multivariate analysis of significant factors identified age of 75 or more and non-CBP as an independent risk factor for incisional SSI (HR=9.5; p=0.049 and HR=5.4×e
-8 ; p=0.020)., Conclusion: Preoperative CBP in addition to MBP was effective in preventing incisional SSI during colorectal cancer surgery., (Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
293. Antimicrobial Activity of Positively Charged Oligopeptides with Theoretical High α-Helix Content against Cutibacterium acnes .
- Author
-
Yoshida M, Hayashi S, Haraguchi T, Ito M, Hatanaka Y, Yoshii M, Tatsuoka H, Tanaka S, and Nagao T
- Subjects
- Protein Conformation, alpha-Helical, Propionibacteriaceae drug effects, Humans, Hydrogen-Ion Concentration, Anti-Infective Agents pharmacology, Anti-Infective Agents chemistry, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Microbial Sensitivity Tests, Oligopeptides chemistry, Oligopeptides pharmacology, Candida albicans drug effects
- Abstract
Cutibacterium acnes is abundant and commonly exists as a superficial bacteria on human skin. Recently, the resistance of C. acnes to antimicrobial agents has become a serious concern, necessitating the development of alternative pharmaceutical products with antimicrobial activity against C. acnes . To address this need, we evaluated the antimicrobial activity of CKR-13-a mutant oligopeptide of FK-13 with increased net charge and theoretical α-helical content-against C. acnes in modified Gifu Anaerobic Medium broth by determining the minimum inhibitory concentration (MIC). CKR-13 exerted greater antimicrobial activity against C. acnes than FK-13 in the broth at pH 7.0. The antimicrobial activity of CKR-13 with RXM against C. albicans was pH-dependent. The ionization of CKR-13 and pH-dependent growth delay of C. albicans was suggested to be associated with the increase in CKR-13 antimicrobial activity., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
294. Synthesis and Photophysical Characterization of Fluorescent Naphtho[2,3- d ]thiazole-4,9-Diones and Their Antimicrobial Activity against Staphylococcus Strains.
- Author
-
Hagimori M, Hara F, Mizuyama N, Takada S, Hayashi S, Haraguchi T, Hatanaka Y, Nagao T, Tanaka S, Yoshii M, and Yoshida M
- Subjects
- Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemical synthesis, Anti-Bacterial Agents chemistry, Staphylococcus drug effects, Staphylococcus growth & development, Molecular Structure, Structure-Activity Relationship, Anti-Infective Agents pharmacology, Anti-Infective Agents chemistry, Anti-Infective Agents chemical synthesis, Fluorescent Dyes chemistry, Fluorescent Dyes chemical synthesis, Fluorescent Dyes pharmacology, Microbial Sensitivity Tests, Thiazoles chemistry, Thiazoles pharmacology, Thiazoles chemical synthesis
- Abstract
The chemical reaction of 2-(methylsulfinyl)naphtho[2,3- d ]thiazole-4,9-dione ( 3 ) using different amines, including benzylamine ( 4a ), morpholine ( 4b ), thiomorpholine ( 4c ), piperidine ( 4d ), and 4-methylpiperazine ( 4e ), produced corresponding new tricyclic naphtho[2,3- d ]thiazole-4,9-dione compounds ( 5a - e ) in moderate-to-good yields. The photophysical properties and antimicrobial activities of these compounds ( 5a - e ) were then characterized. Owing to the extended π-conjugated system of naphtho[2,3- d ]thiazole-4,9-dione skeleton and substituent effect, 5a - e showed fluorescence both in solution and in the solid state. The introduction of nitrogen-containing heterocycles at position 2 of the thiazole ring on naphtho[2,3- d ]thiazole-4,9-dione led to large bathochromic shifts in solution, and 5b - e exhibited orange-red fluorescence with emission maxima of over 600 nm in highly polar solvents. Staphylococcus aureus ( S. aureus ) is a highly pathogenic bacterium, and infection with its antimicrobial-resistant pathogen methicillin-resistant S. aureus (MRSA) results in serious clinical problems. In this study, we also investigated the antimicrobial activities of 5a - e against S. aureus , MRSA, and S. epidermidis . Compounds 5c with thiomorpholine group and 5e with 4-methylpiperazine group showed potent antimicrobial activity against these bacteria. These results will lead to the development of new fluorescent dyes with antimicrobial activity in the future.
- Published
- 2024
- Full Text
- View/download PDF
295. Biological variation of 16 biochemical analytes estimated from a large clinicopathologic database of dogs and cats.
- Author
-
Tamamoto T, Miki Y, Sakamoto M, Yoshii M, Yamada M, Sudo D, Fusato Y, Ozawa J, and Satake C
- Subjects
- Dogs, Animals, Cats, Reference Values, Male, Female, Blood Chemical Analysis veterinary, Databases, Factual
- Abstract
Background: Biochemical measurements are commonly evaluated using population-based reference intervals; however, there is a growing trend toward reassessing results with within-subject variation (CV
I )., Objectives: We aimed to estimate the CVI of 16 biochemical analytes using a large database of dogs and cats, which refers to the results of routine health checkups., Methods: Pairs of sequential results for 16 analytes were extracted from a database of adult patients. The second result was divided by the first result to produce the ratio of sequential results (rr), and the frequency distribution of rr was plotted. From the plots, the coefficient of variation (CVrr ) was calculated. Analytical variation (CVA ) was calculated using quality control data, and CVI was estimated as follows: CV I = CV rr / 2 1 / 2 2 - CV A 2 1 / 2 . Estimated CVI was compared with previously reported CVI using the Bland-Altman plot analysis., Results: From the database, 9078 data points from 3610 dogs and 3743 data points from 1473 cats were extracted, with 5468 data pairs for dogs and 2270 for cats. Sampling intervals ranged from 10 to 1970 days (median 366) for dogs and 23 to 1862 days (median 365) for cats. Bland-Altman analysis showed most CVI plots fell within the limits of agreement; however, positive fixed biases were observed in both dogs and cats., Conclusions: Our study introduces a novel approach of estimating CVI using routine health checkup data in dogs and cats. Despite biases, our method holds promise for clinical application in assessing the significance of measurement result differences., (© 2024 The Authors. Veterinary Clinical Pathology published by Wiley Periodicals LLC on behalf of American Society for Veterinary Clinical Pathology.)- Published
- 2024
- Full Text
- View/download PDF
296. Optimal extent of lymph node dissection for high-risk gastric cancer stratified by a national clinical database risk calculator.
- Author
-
Kuroda K, Miki Y, Kasashima H, Yoshii M, Fukuoka T, Tamura T, Shibutani M, Toyokawa T, Lee S, and Maeda K
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Risk Assessment methods, Japan epidemiology, Databases, Factual, Adult, Aged, 80 and over, Postoperative Complications epidemiology, Prognosis, Treatment Outcome, Stomach Neoplasms surgery, Stomach Neoplasms pathology, Stomach Neoplasms mortality, Lymph Node Excision methods, Gastrectomy methods
- Abstract
Background: For patients with gastric cancer, a well-balanced treatment that considers both oncological aspects and surgical risk is demanded. This study aimed to explore the optimal extent of lymph node dissection (LND) for patients with gastric cancer according to surgical risk, stratified by the risk calculator system produced by the Japan National Clinical Database (NCD)., Patients and Methods: We retrospectively evaluated 187 patients who underwent radical gastrectomy for gastric cancer. Using the median predicted anastomotic leak rate obtained by the NCD risk calculator as the cutoff value, we classified 97 and 90 patients as having high and low risks, respectively., Results: In low-risk patients, although limited LND reduced the postoperative intraabdominal infectious complications (IAIC), multivariate analysis revealed standard LND as an independent prognostic factor that improved Relapse-free survival (RFS). In high-risk patients, the rates of postoperative IAIC and RFS were similar between standard and limited LND. Pancreatic fistula was not observed in the limited dissection group., Conclusion: Limited LND might be the optimal treatment strategy for patients with gastric cancer with high surgical risk., (© 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).)
- Published
- 2024
- Full Text
- View/download PDF
297. Protocol of a pilot randomized clinical trial to evaluate nutritional support and rehabilitation on prevention of skeletal muscle mass loss during neoadjuvant chemotherapy in patients with esophageal cancer.
- Author
-
Miki Y, Nishi S, Tamura T, Imai T, Nambara M, Fukuoka T, Yoshii M, Toyokawa T, Lee S, Fujii H, Yoshida H, Ikebuchi M, and Maeda K
- Subjects
- Humans, Pilot Projects, Prospective Studies, Muscle, Skeletal pathology, Nutritional Support, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Esophagectomy adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Neoadjuvant Therapy methods, Esophageal Neoplasms drug therapy, Esophageal Neoplasms surgery, Esophageal Neoplasms pathology
- Abstract
Background: Subtotal esophagectomy with lymph node dissection followed by neoadjuvant chemotherapy (NAC) is the standard treatment for stage II-III esophageal cancer. Esophagectomy is still associated with high morbidity rates, and reducing these rates remains challenging. Among several complications, postoperative pneumonia (PP) is sometimes fatal, which has been reportedly caused by sarcopenia. Thus, nutritional support and rehabilitation may be promising for preventing skeletal muscle mass loss and reduce the incidence of PP., Methods: This single-center, randomized, open-label, pilot trial will randomize a total of 40 patients with esophageal cancer in a 1:1 ratio either to ISOCAL Clear + rehabilitation arm or only rehabilitation arm. Although all patients will be educated about rehabilitation by a specialized physician and will be asked to undergo the prespecified rehabilitation program, patients treated with ISOCAL Clear + rehabilitation arm will be supplemented by 400 mL of ISOCAL Clear (Nestlé Japan Ltd, Tokyo, Japan) per day during two courses of NAC with docetaxel, cisplatin, and fluorouracil. Body composition will be assessed using Inbody (Inbody Co., Ltd., Tokyo, Japan) just before starting NAC and surgery. The primary endpoint is the change of skeletal muscle index (SMI) during NAC. Secondary endpoints include (i) body weight, total skeletal muscle mass, appendicular skeletal muscle mass, and lean body mass index changes; (ii) the percentage of ISOCAL Clear continuation; (iii) appetite evaluation; (iv) the percentage of targeted calorie achievement; (v) adverse events of NAC; (vi) postoperative complication rates; and (vii) postoperative hospital stay., Discussion: This prospective trial assesses the efficacy of nutritional support in addition to rehabilitation during NAC for patients with esophageal cancer. The results will be utilized in assessing whether the effects of nutritional support by ISOCAL Clear are promising or not and in planning future larger clinical trials., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Miki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
298. Prognostic significance of connective tissue growth factor expression in stromal cells in patients with diffuse‑type gastric cancer.
- Author
-
Miki Y, Yoshii M, Miyauchi R, Kasashima H, Fukuoka T, Tamura T, Shibutani M, Toyokawa T, Lee S, Yashiro M, and Maeda K
- Abstract
Connective tissue growth factor (CTGF) is a target gene of the Hippo signaling pathway. Its differential role in the histological types of gastric cancer (GC) remains unknown; therefore, the present study aimed to confirm the clinical significance of CTGF expression in cancer and stromal cells in patients with GC depending on the histological type. The present study enrolled 589 patients with GC. Immunohistochemistry was used to analyze CTGF expression in cancer and stromal cells. CTGF mRNA expression data and the corresponding clinical information of GC samples were collected from The Cancer Genome Atlas (TCGA) database. Subsequently, the associations between CTGF expression and several clinicopathological factors were investigated. In the present study, CTGF expression was mainly observed in the cytoplasm of cancer and stromal cells. CTGF expression in stromal cells was significantly associated with CTGF expression in cancer cells (P<0.001). CTGF positivity in stromal cells was also significantly associated with intestinal type, non-scirrhous type, tumor depth (T1-2), lymph node metastasis (negative), lymphatic invasion (negative) and tumor size (<5 cm). Low CTGF expression in stromal cells was independently associated with worse overall survival (OS). Furthermore, the OS of patients with low CTGF expression in stromal cells, especially in patients with diffuse-type GC, was significantly worse than patients with high CTGF expression (P=0.022). This trend was similar to that revealed by TCGA data analysis. In conclusion, low CTGF expression was associated with a significantly worse OS in patients with diffuse-type GC. These data indicated that CTGF, and its control by the Hippo pathway, may be considered potential treatment targets in diffuse-type GC., Competing Interests: The authors declare that they have no competing interests., (Copyright: © 2024 Miki et al.)
- Published
- 2024
- Full Text
- View/download PDF
299. An 8-mm port site hernia after robotic-assisted ileocecal resection: a case report.
- Author
-
Ahn C, Shibutani M, Kitayama K, Kasashima H, Miki Y, Yoshii M, Fukuoka T, Tamura T, Toyokawa T, Lee S, and Maeda K
- Abstract
Background: Robotic-assisted surgery is steadily becoming more prominent. The majority of reports regarding port site hernias (PSHs) have involved laparoscopic procedures. Currently, it is common to suture the fascia at port sites that are 10 mm or larger; however, the closure of 5-mm port sites is not considered mandatory. The da Vinci
® surgical system (Intuitive Surgical Inc., Sunnyvale, CA, USA) utilizes a distinctive 8-mm port. We report a case of an early-onset PSH at an 8-mm port site after robotic-assisted ileocecal resection., Case Presentation: A 74-year-old male patient with a body mass index of 19.7 kg/m2 was diagnosed with cecal cancer and underwent robotic-assisted ileocecal resection. A 3-cm midline incision was made at the umbilicus for insufflation. Under laparoscopic visualization, three ports (12 mm, 8 mm, and 8 mm) were inserted in the lower abdomen. An 8-mm port was inserted in the left subcostal region, and a 5-mm port was inserted in the left lateral abdomen. The procedure was performed without significant intraoperative complications. The fascia was closed only at the umbilicus and 12-mm port site; the fascia at the 8-mm port sites was not closed. The patient was initially discharged without complications; however, on postoperative day 11, the patient was urgently hospitalized again because of PSH incarceration. After manual reduction, the fascia was sutured closed under local anesthesia. The hernial defect was small and barely allowed the insertion of a little finger. There was no evidence of compression or significant damage to the fascia. On postoperative day 27, the patient was discharged after experiencing good recovery., Conclusions: Robotic-assisted colectomy could contribute to the risk of PSHs because of its surgical characteristics. Although routine closure of the fascia at 8-mm port sites is not mandatory, it may be beneficial in certain cases., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
300. Antimicrobial Activity of 2-(Piperazin-1-yl)naphtho[2,3-d]thiazole-4,9-dione against Staphylococcus Strains.
- Author
-
Haraguchi T, Hayashi S, Nakasaka S, Hatanaka Y, Nagao T, Tanaka S, Yoshii M, Hara F, Hagimori M, and Yoshida M
- Subjects
- Thiazoles pharmacology, DNA Gyrase genetics, Anti-Bacterial Agents pharmacology, Microbial Sensitivity Tests, Staphylococcus, Methicillin-Resistant Staphylococcus aureus
- Abstract
There is an urgent need to discover and develop novel antibacterial agents. Accordingly, we synthesised 2-(piperazin-1-yl)naphtho[2,3-d]thiazole-4,9-dione (PNT), which exhibits antimicrobial activity. The aim of this study was to characterise PNT as an effective antimicrobial agent. Fluorescence microscopy was used to measure PNT's uptake into microbial cells (strains of Staphylococcus epidermidis , Staphylococcus aureus , and methicillin-resistant S. aureus (MRSA)), transmission electron microscopy (TEM) was used to investigate the influence of PNT on the configuration of microbial cells, and a DNA gyrase supercoiling assay was used to investigate whether PNT inhibits DNA gyrase. PNT was taken up by more than 50% of microbial cells within 30 min. Using TEM, hollowed-out bacterial cytoplasms were observed in the specimen treated with PNT, although there was no disintegration of the bacterial membrane. In the DNA gyrase supercoiling assay, a dose-dependent reduction in fluorescence intensity was observed as the concentration of PNT increased. This suggests that PNT is taken up by microbial cells, resulting in cell disruption, and it reveals that one of the mechanisms underlying the antimicrobial activity of PNT is the inhibition of DNA gyrase.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.